-
Je něco špatně v tomto záznamu ?
Clonal evolution in chronic lymphocytic leukemia studied by interphase fluorescence in-situ hybridization
A. Berková, Z. Zemanová, M. Trněný, J. Schwarz, J. Karban, E. Cmunt, L. Pavlištová, J Březinová, K. Michalová
Jazyk angličtina Země Slovensko
Typ dokumentu práce podpořená grantem
Grantová podpora
NR9244
MZ0
CEP - Centrální evidence projektů
PubMed
19580349
DOI
10.4149/neo_2009_05_455
Knihovny.cz E-zdroje
- MeSH
- antigeny CD38 analýza MeSH
- chromozomální aberace MeSH
- chronická lymfatická leukemie genetika MeSH
- dospělí MeSH
- hybridizace in situ fluorescenční metody MeSH
- interfáze MeSH
- lidé středního věku MeSH
- lidé MeSH
- protein-tyrosinkináza ZAP-70 analýza MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- práce podpořená grantem MeSH
The results of repeated interphase fluorescence in-situ hybridization (I-FISH, FISH) examination of 97 CLL patients and correlation of these findings with IgVH hypermutation status, ZAP-70 and CD38 expression are presented. The appearance of new, FISH-detectable, genomic aberrations during disease course, described as clonal evolution (CE), was observed in 26% of patients. The most frequent newly acquired cytogenetic abnormality was 13q deletion in 64% (16/25). In contrast to earlier studies, there was no correlation found between CE and either one of single negative prognostic factors (unmutated IgVH; CD38 positivity; ZAP-70 positivity). However, the combination of all three negative factors correlated with CE highly significantly (p=0.005) and moreover, also with a shift from lower to higher FISH risk category (p=0.010). As the prognostic data were known in all patients, this study represents the complete insight on the association of CE and other risk parameters in CLL.
Citace poskytuje Crossref.org
- 000
- 02624naa 2200457 a 4500
- 001
- bmc11016752
- 003
- CZ-PrNML
- 005
- 20241204105119.0
- 008
- 110628s2009 xo e eng||
- 009
- AR
- 024 __
- $a 10.4149/neo_2009_05_455 $2 doi
- 035 __
- $a (PubMed)19580349
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Berková, Adéla $7 xx0325890
- 245 10
- $a Clonal evolution in chronic lymphocytic leukemia studied by interphase fluorescence in-situ hybridization / $c A. Berková, Z. Zemanová, M. Trněný, J. Schwarz, J. Karban, E. Cmunt, L. Pavlištová, J Březinová, K. Michalová
- 314 __
- $a Institute of Clinical Biochemistry and Laboratory Diagnostics, Charles University, Prague, Czech Republic. adela.berkova@yahoo.com
- 520 9_
- $a The results of repeated interphase fluorescence in-situ hybridization (I-FISH, FISH) examination of 97 CLL patients and correlation of these findings with IgVH hypermutation status, ZAP-70 and CD38 expression are presented. The appearance of new, FISH-detectable, genomic aberrations during disease course, described as clonal evolution (CE), was observed in 26% of patients. The most frequent newly acquired cytogenetic abnormality was 13q deletion in 64% (16/25). In contrast to earlier studies, there was no correlation found between CE and either one of single negative prognostic factors (unmutated IgVH; CD38 positivity; ZAP-70 positivity). However, the combination of all three negative factors correlated with CE highly significantly (p=0.005) and moreover, also with a shift from lower to higher FISH risk category (p=0.010). As the prognostic data were known in all patients, this study represents the complete insight on the association of CE and other risk parameters in CLL.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a antigeny CD38 $x analýza $7 D051997
- 650 _2
- $a chromozomální aberace $7 D002869
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hybridizace in situ fluorescenční $x metody $7 D017404
- 650 _2
- $a interfáze $7 D007399
- 650 _2
- $a chronická lymfatická leukemie $x genetika $7 D015451
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a protein-tyrosinkináza ZAP-70 $x analýza $7 D051746
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zemanová, Zuzana, $d 1962- $7 nlk20050170627
- 700 1_
- $a Trněný, Marek, $d 1960- $7 nlk20000083659
- 700 1_
- $a Schwarz, Jiří, $d 1957- $7 xx0052837
- 700 1_
- $a Karban, Josef $7 stk2007415539
- 700 1_
- $a Cmunt, Eduard, $d 1952- $7 xx0106898
- 700 1_
- $a Pavlištová, Lenka $7 xx0128185
- 700 1_
- $a Březinová, Jana, $d 1958- $7 xx0046958
- 700 1_
- $a Michalová, Kyra, $d 1942- $7 nlk19990073558
- 773 0_
- $t Neoplasma $g Roč. 56, č. 5 (2009), s. 455-458 $x 0028-2685 $w MED00003470
- 910 __
- $a ABA008 $b A 1194 $y 2 $z 0
- 990 __
- $a 20110720121753 $b ABA008
- 991 __
- $a 20241204105114 $b ABA008
- 999 __
- $a ok $b bmc $g 864066 $s 726543
- BAS __
- $a 3
- BMC __
- $a 2009 $b 56 $c 5 $d 455-458 $i 0028-2685 $m Neoplasma $n Neoplasma $x MED00003470
- GRA __
- $a NR9244 $p MZ0
- LZP __
- $a 2011-3B09/BBjvme